These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15723810)

  • 1. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.
    Zwart W; Griekspoor A; Kuijl C; Marsman M; van Rheenen J; Janssen H; Calafat J; van Ham M; Janssen L; van Lith M; Jalink K; Neefjes J
    Immunity; 2005 Feb; 22(2):221-33. PubMed ID: 15723810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
    Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
    J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
    Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
    Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
    Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
    J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
    Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
    J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases.
    Lem L; Riethof DA; Scidmore-Carlson M; Griffiths GM; Hackstadt T; Brodsky FM
    J Immunol; 1999 Jan; 162(1):523-32. PubMed ID: 9886429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
    Belmares MP; Busch R; Mellins ED; McConnell HM
    Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-D Structure of multilaminar lysosomes in antigen presenting cells reveals trapping of MHC II on the internal membranes.
    Murk JL; Lebbink MN; Humbel BM; Geerts WJ; Griffith JM; Langenberg DM; Verreck FA; Verkleij AJ; Koster AJ; Geuze HJ; Kleijmeer MJ
    Traffic; 2004 Dec; 5(12):936-45. PubMed ID: 15522096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the HLA-DM/HLA-DR interface.
    Davies MN; Lamikanra A; Sansom CE; Flower DR; Moss DS; Travers PJ
    Mol Immunol; 2008 Feb; 45(4):1063-70. PubMed ID: 17870168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
    Ferrari G; Knight AM; Watts C; Pieters J
    J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics within tetraspanin pairs affect MHC class II expression.
    Hoorn Tv; Paul P; Janssen L; Janssen H; Neefjes J
    J Cell Sci; 2012 Jan; 125(Pt 2):328-39. PubMed ID: 22302999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
    Chamuleau ME; Souwer Y; Van Ham SM; Zevenbergen A; Westers TM; Berkhof J; Meijer CJ; van de Loosdrecht AA; Ossenkoppele GJ
    Cancer Res; 2004 Aug; 64(16):5546-50. PubMed ID: 15313888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments.
    Haug M; Schepp CP; Kalbacher H; Dannecker GE; Holzer U
    Eur J Immunol; 2007 Apr; 37(4):1053-63. PubMed ID: 17357109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation.
    Ma C; Blum JS
    J Immunol; 1997 Jan; 158(1):1-4. PubMed ID: 8977167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
    van Lith M; van Ham M; Neefjes J
    Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
    Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
    Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.